Evaluating Stairway Designs for Individuals With Vision Impairment

NCT ID: NCT07337317

Last Updated: 2026-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to learn if contrast frequency on step tread-edges influences foot clearance measures, a marker of fall risk, in older adults with and without visual impairments.

The main questions that aim to be answered are how foot clearance measures change across different frequencies of stair contrast, and how experiences and perceptions of different stair contrast frequencies are evaluated.

Researchers will compare individuals with and without visual impairments to see if contrast frequency on step tread-edges changes.

Participants will attend one visit during which their vision will be measured, and they will be asked to ascend and descend laboratory stairs at different contrast frequencies.

An optional second visit will entail a focus group meeting to better understand how contrast affects mobility in their home and everyday life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vision, Low Mobility Limitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Four contrast frequency conditions by two lighting conditions (N = 8) will be evaluated. The four frequencies are (1) contrast markings added to all steps, (2) contrast markings added to the first, last step, (3) contrast markings added to the first, two and last, two steps, (4) no contrast markings on stairs, in both low light and standard lighting conditions
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

All participants will participate in the experimental arm, that involves a factorial model approach inwhich all participants will experience all eight conditions.

Group Type EXPERIMENTAL

Frequency of contrast marking on stair steps

Intervention Type OTHER

Frequency of contrast marking on stair steps will be evaluated to determine how foot clearance, perceptions in older adults with and without impaired contrast sensivity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Frequency of contrast marking on stair steps

Frequency of contrast marking on stair steps will be evaluated to determine how foot clearance, perceptions in older adults with and without impaired contrast sensivity

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ≥ Contrast sensitivity log 1.6 or greater
2. travels independently in the community, including stairways \> two times/week
3. comfortable ascending and descending a stairway with rest time provided

Exclusion Criteria

4. severe rheumatologic and or orthopedic diseases (e.g., awaiting joint replacement, active inflammatory disease)
5. lower-limb injuries and/or recent joint replacements (e.g., hip fracture, hip, or knee replacement within six months of study enrollment)
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Alabama in Huntsville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Harper

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara A Harper, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama in Huntsville

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama in Huntsville

Huntsville, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara A Harper, PhD

Role: CONTACT

2568242184

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sara A Harper, PhD

Role: primary

2568242184

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Innovative Shoe for People With Foot Drop
NCT06911151 NOT_YET_RECRUITING NA